UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 619

Sortiert nach

Differential diagnosis of suspected multiple sclerosis: a consensus approach

Multiple sclerosis, 2008-11, Vol.14 (9), p.1157-1174

2008

Volltextzugriff (PDF)

Postmortem verification of MS cortical lesion detection with 3D DIR

Neurology, 2012-01, Vol.78 (5), p.302

2012

Volltextzugriff (PDF)

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

Neurology, 2006-10, Vol.67 (7), p.1242

2006

Volltextzugriff (PDF)

Structural degree predicts functional network connectivity: A multimodal resting-state fMRI and MEG study

NeuroImage (Orlando, Fla.), 2014-08, Vol.97, p.296-307

2014

Volltextzugriff (PDF)

Functional brain network analysis using minimum spanning trees in Multiple Sclerosis: An MEG source-space study

NeuroImage (Orlando, Fla.), 2014-03, Vol.88, p.308-318

2014

Volltextzugriff (PDF)

EFNS guidelines on diagnosis and management of neuromyelitis optica

European journal of neurology, 2010-08, Vol.17 (8), p.1019-1032

2010

Volltextzugriff (PDF)

Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration

Multiple sclerosis, 2014-01, Vol.20 (1), p.72-80

2014

Volltextzugriff (PDF)

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS

Neurology, 2007-04, Vol.68 (17), p.1390

2007

Volltextzugriff (PDF)

Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis

Multiple sclerosis, 2014-04, Vol.20 (4), p.412-417

2014

Volltextzugriff (PDF)

Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2015-04, Vol.86 (4), p.419-424

2015

Volltextzugriff (PDF)

Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease

Brain (London, England : 1878), 2009-05, Vol.132 (5), p.1190-1199

2009

Volltextzugriff (PDF)

Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis

Neurology, 2009-02, Vol.72 (7), p.595

2009

Volltextzugriff (PDF)

Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS

Neurology, 2004-07, Vol.63 (2), p.335

2004

Volltextzugriff (PDF)

Disease course heterogeneity and OCT in multiple sclerosis

Multiple sclerosis, 2014-08, Vol.20 (9), p.1198-1206

2014

Volltextzugriff (PDF)

Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency

Neurology, 2010-11, Vol.75 (18), p.1617

2010

Volltextzugriff (PDF)

Changes in functional network centrality underlie cognitive dysfunction and physical disability in multiple sclerosis

Multiple sclerosis, 2014-07, Vol.20 (8), p.1058-1065

2014

Volltextzugriff (PDF)

Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development

Multiple sclerosis, 2014-04, Vol.20 (5), p.577-587

2014

Volltextzugriff (PDF)

Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks

Multiple sclerosis, 2010-11, Vol.16 (11), p.1385-1392

2010

Volltextzugriff (PDF)

Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients

Neurology, 2008-03, Vol.70 (13 Pt 2), p.1150

2008

Volltextzugriff (PDF)

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL

Journal of neurology, 2009-03, Vol.256 (3), p.405-415

2009

Volltextzugriff (PDF)

Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination

Neurology, 2004-01, Vol.62 (2), p.226

2004

Volltextzugriff (PDF)

Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis

Neurology, 1998-05, Vol.50 (5), p.1282

1998

Volltextzugriff (PDF)

Natalizumab reduces visual loss in patients with relapsing multiple sclerosis

Neurology, 2007-04, Vol.68 (16), p.1299

2007

Volltextzugriff (PDF)

Multiple sclerosis and vitamin D: an update

European journal of clinical nutrition, 2004-08, Vol.58 (8), p.1095-1109

2004

Volltextzugriff (PDF)

Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis

Multiple sclerosis, 2006-10, Vol.12 (5), p.594-598

2006

Volltextzugriff (PDF)

1 – 25 von 619

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(560)
Mit Volltextzugriff
(481)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Multiple Sclerosis
(112)
Neurology
(67)
Journal Of Neuroimmunology
(38)
Annals Of Neurology
(30)
Journal Of Neurology, Neurosurgery And Psychiatry
(26)
Journal Of Neurology
(19)
Brain
(18)
The Lancet
(14)
Archives Of Neurology
(13)
American Journal Of Neuroradiology : Ajnr
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Differential diagnosis of suspected multiple sclerosis: a consensus approach

Postmortem verification of MS cortical lesion detection with 3D DIR

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

Structural degree predicts functional network connectivity: A multimodal resting-state fMRI and MEG study

Functional brain network analysis using minimum spanning trees in Multiple Sclerosis: An MEG source-space study

EFNS guidelines on diagnosis and management of neuromyelitis optica

Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS

Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis

Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis

Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease

Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis

Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS

Disease course heterogeneity and OCT in multiple sclerosis

Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency

Changes in functional network centrality underlie cognitive dysfunction and physical disability in multiple sclerosis

Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development

Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks

Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL

Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination

Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis

Natalizumab reduces visual loss in patients with relapsing multiple sclerosis

Multiple sclerosis and vitamin D: an update

Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis

Suchergebnisse filtern